Systems, Devices, and/or Methods for Managing Transdermal Patches

US 10,661,065, assigned to N Brereton Medical Technologies LLC, covers a system for manually controlling the delivery of a transdermally-delivered medication, and is available for sale through IPApproach.

US Patents

1 granted

Assignee

N Brereton Medical Technologies LLC

Availability

For Sale

Patents Included

• US 10,661,065↗

Technology Highlights

• It maintain the lower dose of medication and further control the delivery flow rate of medication to the skin of patient using flux controller.
• The transdermal patch offers a continuous, sustained release of drug and avoids daily peak and trough hormone levels.
• Flux controller consists of impermeable portion containing apertures which allow the medication to permeate from patch to skin.

Listing updated August 21, 2026

IPApproach lists patents and portfolios where the seller has not requested anonymity or confidentiality. Patent numbers link to public records on Google Patents.